Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments.
Affiliation
Clinical Oncology Department, Christie Hospital NHS Trust, Manchester, UK. corinne.finn@christie-tr.nwest.nhs.ukIssue Date
2005-12
Metadata
Show full item recordAbstract
Thoracic radiotherapy has an established role in the management of limited-disease small-cell lung cancer (LD SCLC). However, essential questions relating to the optimisation of thoracic radiotherapy remain unanswered, including volume of irradiation, optimal total dose, fractionation, timing and sequencing of radiation. This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC.Citation
Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments. 2005, 17 (8):591-8 Clin OncolJournal
Clinical OncologyPubMed ID
16372483Type
ArticleLanguage
enISSN
0936-6555Collections
Related articles
- Radiotherapy for small-cell lung cancer-Where are we heading?
- Authors: Bayman NA, Sheikh H, Kularatne B, Lorigan P, Blackhall F, Thatcher N, Faivre-Finn C
- Issue date: 2009 Mar
- [Treatment of small cell lung cancer: limited diseases. Guidelines of clinical practice made by the European Lung Cancer Working Party].
- Authors: European Lung Cancer Working Party.
- Issue date: 2008 May-Jun
- Thoracic irradiation of limited small cell lung cancer: have we defined optimal dose, time, and fractionation?
- Authors: Wagner H Jr
- Issue date: 1997 Jun
- The role of thoracic radiotherapy in the management of limited-stage small cell lung cancer: past, present, and future.
- Authors: Kumar P
- Issue date: 1997 Oct
- Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
- Authors: Turrisi AT 3rd
- Issue date: 1994 Jun